Spark Therapeutics Stock
Your prediction
Pros and Cons of Spark Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Spark Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ironwood Pharmaceuticals | 3.290% | -3.797% | 84.242% | -12.644% | -27.619% | -72.543% | -69.293% |
| Novocure Ltd | 3.110% | 11.759% | 16.191% | -59.936% | -61.161% | -84.188% | -91.887% |
| Iovance Biotherapeutics Inc. | -3.090% | 2.465% | -5.304% | -76.280% | -71.952% | -70.459% | -95.240% |
News
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December
Prediction: Nvidia Stock Could Reach $360 Sooner Than You Think
Nvidia (NASDAQ: NVDA) is transforming from a graphics processing unit (GPU) champion to an artificial intelligence (AI) infrastructure cash engine. Learn about Blackwell, DGX Spark, and DGX Cloud
